1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1-one

From WikiMD's Wellness Encyclopedia


1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1-one is a chemical compound that has garnered interest in the field of medicinal chemistry due to its potential pharmacological properties. This compound is part of the broader class of heterocyclic compounds, which are characterized by rings containing atoms of at least two different elements as members of its ring(s).

Structure and Properties[edit | edit source]

1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1-one is a fused heterocyclic compound, meaning it consists of multiple rings that share atoms. The structure includes an oxadiazole ring fused to a quinoxaline moiety. The presence of nitrogen and oxygen atoms in the ring system contributes to its unique chemical properties, such as electron distribution and potential for hydrogen bonding.

Chemical Formula[edit | edit source]

The molecular formula of 1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1-one is C9H5N3O2. This indicates the presence of nine carbon atoms, five hydrogen atoms, three nitrogen atoms, and two oxygen atoms.

Physical Properties[edit | edit source]

The compound typically appears as a crystalline solid. Its melting point, solubility, and other physical properties can vary depending on the specific substituents attached to the core structure.

Synthesis[edit | edit source]

The synthesis of 1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1-one can be achieved through various organic synthesis methods. A common approach involves the cyclization of appropriate precursors that contain the necessary functional groups to form the oxadiazole and quinoxaline rings. This often requires the use of reagents that facilitate the formation of nitrogen-oxygen and carbon-nitrogen bonds.

Pharmacological Significance[edit | edit source]

1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1-one has been studied for its potential as a pharmacological agent. Compounds with similar structures have been investigated for their roles as enzyme inhibitors, antimicrobial agents, and anticancer agents. The specific biological activity of this compound can be attributed to its ability to interact with biological targets, such as proteins and nucleic acids, through hydrogen bonding and other interactions.

Research and Applications[edit | edit source]

Research into 1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1-one is ongoing, with studies focusing on its synthesis, characterization, and potential applications in medicine. Its unique structure makes it a candidate for drug development, particularly in areas where modulation of specific biological pathways is desired.

Also see[edit | edit source]



Template:Heterocyclic compounds

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD